Ann: Mayne Pharma provides update on capital management timeline, page-25

Return of capital from our Metrics sale . 2012 asset bought using shareholders at the time money together with commercial lending asst recently sold 2022 major US asset obviously increased substantially in capital value over time held . Present Management in their wisdom decided to generously invite anyone interested in financially benefiting from asset sale return of capital to shareholders think its called provided they purchase shares before nominated offer end date ( offer still open to anyone who wants to share in the proceeds from sale ) SINCIRELY HOPE THERE IS NO RETURN OF CAPITAL FROM THIS FARCICAL ARRANGEMENT AN INSULT TO LONG SUFFERING SHAREHOLDERS screwed big time by Richards and his mates . Return of capital should be for those who have held shares for a period of time , supported this stock a standout opportunity to undo some of the damage done , they should rewarded / compensated by asset sale NOT EVERY MAN AND HIS DOG who have contributed nothing , USE the proceeds for SHARE GROWTH . Special dividend offered before company gets into net profit farce pales in comparison to this insane wasteful unfair return of capital arrangement . La la land stuff , hopefully not out of the fat into the fire with this new mob at the top . OK stephencca " not happy sell " thank me for saving you the trouble of saying it .